Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer

A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with... Journal of Interventional Cardiac Electrophysiology https://doi.org/10.1007/s10840-023-01648-z COMMENTAR Y A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer De‑Gang Mo Received: 10 September 2023 / Accepted: 11 September 2023 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 I read the article entitled “Outcomes of Patients with Cancer clinical studies are needed to evaluate the safety and efficacy of Undergoing Percutaneous Left Atrial Appendage Occlusion” LAAO for this specific patient population. In the future, it will by Agarwal et al. [1] with interest. They included 54,900 be crucial to classify cancer patients into different subgroups patients from The National Readmissions Database and con- because the ec ffi acy of the treatment may vary depending on the cluded that patients with active cancer undergoing left atrial type of cancer. Furthermore, treatment options for each patient appendage occlusion (LAAO) may derive similar clinical should be individualized in a clinical setting. Several factors, such benefits, but at the cost of an increased likelihood of peri- as patient tolerance to anticoagulants, financial considerations, procedural complications compared to those without cancer patient preferences, and potential clinical benetfi s, need to be [1]. I would like to engage http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiac Electrophysiology Springer Journals

A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer

Download PDF
1 page

A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer

Abstract

Journal of Interventional Cardiac Electrophysiology https://doi.org/10.1007/s10840-023-01648-z COMMENTAR Y A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer De‑Gang Mo Received: 10 September 2023 / Accepted: 11 September 2023 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 I read the article entitled...
Loading next page...
 
/lp/springer-journals/a-discussion-on-the-efficacy-of-percutaneous-left-atrial-appendage-A15E0V3vR0

References (4)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023
ISSN
1383-875X
eISSN
1572-8595
DOI
10.1007/s10840-023-01648-z
Publisher site
See Article on Publisher Site

Abstract

Journal of Interventional Cardiac Electrophysiology https://doi.org/10.1007/s10840-023-01648-z COMMENTAR Y A discussion on the efficacy of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and cancer De‑Gang Mo Received: 10 September 2023 / Accepted: 11 September 2023 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 I read the article entitled “Outcomes of Patients with Cancer clinical studies are needed to evaluate the safety and efficacy of Undergoing Percutaneous Left Atrial Appendage Occlusion” LAAO for this specific patient population. In the future, it will by Agarwal et al. [1] with interest. They included 54,900 be crucial to classify cancer patients into different subgroups patients from The National Readmissions Database and con- because the ec ffi acy of the treatment may vary depending on the cluded that patients with active cancer undergoing left atrial type of cancer. Furthermore, treatment options for each patient appendage occlusion (LAAO) may derive similar clinical should be individualized in a clinical setting. Several factors, such benefits, but at the cost of an increased likelihood of peri- as patient tolerance to anticoagulants, financial considerations, procedural complications compared to those without cancer patient preferences, and potential clinical benetfi s, need to be [1]. I would like to engage

Journal

Journal of Interventional Cardiac Electrophysiology – Springer Journals

Published: Mar 1, 2024

There are no references for this article.